Team Publications 2023

1. DURAND S, SEIGNEURET F, BURLAUD-GAILLARD J, LEMOINE R, TASSI M, MOREAU A, MOUGEL M, ROINGEARD P, TAUBER C, ROCQUIGNY H. Revisiting formation of nucleoprotein complexes between HIV-1 Gag and genomic RNA during virus assembly by transmission electron microscopy. J Biol Chem 2022 ; 298: 101500.

1. BURN R, VAN HOUTTE F, VERHOYE L, ABOUZEID MESALAM AAA, CIESEK S, ROINGEARD P, WEDEMEYER H, LEROUX-ROELS G, MEULEMAN P. A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection. JHEP Reports 2023, 5:100646.

2. DE SALAZAR A, VIÑUELA L, FUENTES A, TEYSSOU E, CHARPENTIER C, LAMBERT-NICLOT S, SERRANO-CONDE E, PINGARILHO M, FABENI L, DE MONTE A, STEFIC K, PERNO CF, AGUILERA A, FALCES I, DELGADO R, FERNANDES S, DIOGO I, GOMES P, PARASKEVIS D, SANTORO MM, CECCHERINI-SILBERSTEIN F, MARCELIN AG, GARCIA F. Transmitted drug resistance to integrase based first-line HIV antiretroviral regimens in the Mediterranean Europe. Clin Infect Dis 2023, 76:1628-1635.

3. GOMEZ-ESCOBAR E, ROINGEARD P, BEAUMONT E. Current hepatitis C virus vaccine candidates based on the induction of neutralizing antibodies. Viruses 2023, 15: 1151.

4. ARONTHIPPAITOON Y, SZERMAN N, NGO-GIANG-HUONG N, LAPERCHE S, UNGEHEUER MN, SUREAU C, KHAMDUANG W, GAUDY-GRAFFIN C. Are international units of anti-HBs antibodies always indicative of hepatitis B virus neutralizing activity? Vaccines (Basel) 2023,11:791.

5. JAMARD S, HANDALA L, FAUSSAT C, VINCENT N, STEFIC K, GAUDY-GRAFFIN C, MAAKAROUN-VERMESSE Z, LEMAIGNEN A. Resurgence of symptomatic Mpox among vaccinated patients: First clues from a new-onset local cluster. Infect Dis Now 2023, 53:104714.

6. GALLEGO C, JARACZ-ROS A, LAGANA M, MERCIER-NOMÉ F, FUMAGALLI A, ROINGEARD P, HERFS M, PIDOUX G, BACHELERIE F, SCHLECHT-LOUF G. Reprogramming of connexin landscape fosters fast gap junction intercellular communication in human papillomavirus-infected epithelia. Front Cell Infect Microbiol 2023, 13:1138232.

7. AZARIAS DA SILVA M, NIOCHE P, SOUDARAMOURTY C, BULL-MAURER A, TIOUAJNI M, KONG D, ZGHIDI-ABOUZID O, PICARD M, MENDES-FRIAS A, SANTA-CRUZ A, CARVALHO A, CAPELA C, PEDROSA J, GIL CASTRO A, LOUBET P, SOTTO A, MULLER L, LEFRANT J-Y, ROGER C, CLARET P-G, DUVNJAK S, TRAN T-A, TOKUNAGA K, SILVESTRE R, CORBEAU P, MAMMANO F, ESTAQUIER J. Repetitive mRNA vaccination is required to improve the quality of broad-spectrum anti-SARS-CoV-2 antibodies in the absence of CXCL13. Science Advances 2023 in press

8. JAMARD S, HANDALA L, FAUSSAT C, VINCENT N, STEFIC K, GAUDY-GRAFFIN C, MAAKAROUN-VERMESSE Z, LEMAIGNEN A. Resurgence of symptomatic Mpox among vaccinated patients: First clues from a new-onset local cluster. Infect Dis Now 2023, 53:104714.

9 . TASSI MF, LE MEUR N, STÉFIC K, GRAMMATICO-GUILLON L. Performance of French medico-administrative databases in epidemiology of infectious diseases: a scoping review. Front Public Health 2023, 11:1161550.

10. RODRÍGUEZ-GARCÍA A, MENNESSON N, HERNANDEZ-IBARBURU G, MORALES ML, GARDERET L, BOUCHEREAU L, ALLAIN-MAILLET S, PIVER E, MARBÁN I, RUBIO D, BIGOT-CORBEL E, MARTÍNEZ-LÓPEZ J, LINARES M, HERMOUET S. Impact of viral hepatitis therapy in multiple myeloma and other monoclonal gammopathies linked to hepatitis B or C viruses. Haematologica 2023 in press